{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:40:48Z","timestamp":1790548848505,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/chi.0b013e31802f5f03","type":"journal-article","created":{"date-parts":[[2007,4,9]],"date-time":"2007-04-09T08:03:11Z","timestamp":1176105791000},"page":"479-488","source":"Crossref","is-referenced-by-count":117,"title":["Venlafaxine ER for the Treatment of Pediatric Subjects With Depression"],"prefix":"10.1016","volume":"46","author":[{"given":"GRAHAM J.","family":"EMSLIE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT L.","family":"FINDLING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAUL P.","family":"YEUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NADIA R.","family":"KUNZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUNFENG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/chi.0b013e31802f5f03_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1097\/chi.0b013e31802f5f03_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/00004583-199811000-00029","article-title":"Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. American Academy of Child and Adolescent Psychiatry","volume":"37","author":"Birmaher","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00004583-200301000-00007","article-title":"Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial","volume":"42","author":"Braconnier","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1469-7610.2005.01467.x","article-title":"Review of the efficacy and safety of antidepressants in youth depression","volume":"46","author":"Cheung","year":"2005","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib5","first-page":"55","article-title":"Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience","volume":"57","author":"DeVane","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00004583-200210000-00010","article-title":"Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial","volume":"41","author":"Emslie","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00004583-199706000-00015","article-title":"Recurrence of major depressive disorder in hospitalized children and adolescents","volume":"36","author":"Emslie","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1520-6394(1998)7:1<32::AID-DA4>3.0.CO;2-7","article-title":"Fluoxetine in child and adolescent depression: acute and maintenance treatment","volume":"7","author":"Emslie","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1097\/chi.0b013e31802f5f03_bib10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression","volume":"54","author":"Emslie","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00004583-200106000-00012","article-title":"Adult psychosocial outcome of prepubertal major depressive disorder","volume":"40","author":"Geller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.62.2.165","article-title":"The relationship between antidepressant medication use and rate of suicide","volume":"62","author":"Gibbons","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4088\/JCP.v65n1103","article-title":"Antidepressants and suicide risk in the United States, 1985\u20131999","volume":"65","author":"Grunebaum","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib15","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised 1976","first-page":"217","article-title":"CGI Clinical Global Impressions.","author":"Guy","year":"1976"},{"key":"10.1097\/chi.0b013e31802f5f03_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00004583-200107000-00010","article-title":"Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial","volume":"40","author":"Keller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1520-6394(1998)7:1<3::AID-DA2>3.0.CO;2-F","article-title":"Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey","volume":"7","author":"Kessler","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1097\/chi.0b013e31802f5f03_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00004583-199706000-00008","article-title":"Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents","volume":"36","author":"Leonard","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib22","first-page":"149","article-title":"Venlafaxine in the treatment of children and adolescents with major depression","volume":"33","author":"Mandoki","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/chi.0b013e31802f5f03_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/cap.2006.16.25","article-title":"Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis","volume":"16","author":"Mosholder","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/chi.0b013e31802f5f03_bib25","first-page":"979","article-title":"Children's depression rating scale-revised","volume":"21","author":"Poznanski","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1097\/chi.0b013e31802f5f03_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-199505000-00009","article-title":"Unipolar depression in adolescents: clinical outcome in adulthood","volume":"34","author":"Rao","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib27","first-page":"83","article-title":"SSRIs in children and adolescents: where do we stand?","volume":"3","author":"Sood","year":"2004","journal-title":"Curr Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib28","unstructured":"U.S. Food and Drug Administration (2006), Historical Information on Fluoxetine Hydrochloride (marketed as Prozac). Available at: http:\/\/www.fda.gov\/cder\/drug\/infopage\/fluoxetine\/historical.htm. Accessed October 9, 2006"},{"key":"10.1097\/chi.0b013e31802f5f03_bib29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"10.1097\/chi.0b013e31802f5f03_bib30","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ajp.161.6.1079","article-title":"A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents","volume":"161","author":"Wagner","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1097\/chi.0b013e31802f5f03_bib31","series-title":"American Psychiatric Publishing Textbook of Child and Adolescent Psychiatry","first-page":"437","article-title":"Mood disorders in adolescents.","author":"Weller","year":"2004"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709616993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709616993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T10:46:40Z","timestamp":1568198800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709616993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0890856709616993"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e31802f5f03","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}